Posted by Michael Wonder on 07 Sep 2020
Australia secures onshore manufacturing agreements for two COVID-19 vaccines
7 September 2020 - A $1.7 billion agreement between the Australian Government and pharmaceutical companies means that a free COVID-19 vaccine will be available progressively throughout 2021 in Australia, if promising trials prove successful.
A free COVID-19 vaccine will be available progressively throughout 2021 in Australia, if promising trials prove successful, following a $1.7 billion supply and production agreement between the Australian Government and pharmaceutical companies.
Under the agreement, the University of Oxford/AstraZeneca and the University of Queensland/CSL will provide more than 84.8 million vaccine doses for the Australian population, almost entirely manufactured in Melbourne, with early access to 3.8 million doses of the University of Oxford vaccine in January and February 2021.
